Oriol Guitart-Pla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Oriol Guitart-Pla has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Pessia
University of Helsinki
2 shared publications - Andrea Califano
Department of Systems Biology, Columbia University, New York, USA
2 shared publications - Bence Szalai
Affiliations Institute of Molecular Life Sciences, Centre of Excellence of the Hungarian Academy of Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary, Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary
2 shared publications - Charles Karan
Department of Systems Biology, Columbia University Irving Medical Center, 1130 Saint Nicholas Ave, New York, NY USA 10032
2 shared publications Daniela S. Gerhard
Office of Cancer Genomics, National Cancer Institute, NIH, Bethesda, MD 20892, USA
2 shared publications- Fangping Wan
Machine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
2 shared publications
Latest Publications
- Open Access
- 18 January 2022
- Published by Elsevier in Cell Reports Medicine
- Vol. 3 (1) , 100492
A community challenge for a pancancer drug mechanism of action inference from perturbational profile data
- 18 January 2022
- Published by Elsevier in Cell Reports Medicine
- Vol. 3 (1) , 100492
Open AccessA community challenge for a pancancer drug mechanism of action inference from perturbational profile data
- Open Access
A Community Challenge for Pancancer Drug Mechanism of Action Inference from Perturbational Profile Data
The Columbia Cancer Target Discovery and Development (CTD 2 ) Center has developed PANACEA (PANcancer Analysis of Chemical Entity Activity), a collection of dose-response curves and perturbational profiles for 400 clinical oncology drugs in cell lines selected to optimally represent 19 cancer subtypes. This resource, developed to study tumor-specific drug mechanism of action, was instrumental in hosting a DREAM Challenge to assess computational models for de novo drug polypharmacology prediction. Dose-response and perturbational profiles for 32 kinase inhibitors were provided to 21 participating teams who were asked to predict high-affinity binding target among 255 possible protein kinases. Best performing methods leveraged both gene expression profile similarity analysis, and deep-learning methodologies trained on individual datasets. This study lays the foundation for future integrative analyses of pharmacogenomic data, reconciliation of polypharmacology effects in different tumor contexts, and insights into network-based assessment of context-specific drug mechanism of action.
Open AccessA Community Challenge for Pancancer Drug Mechanism of Action Inference from Perturbational Profile Data
The Columbia Cancer Target Discovery and Development (CTD 2 ) Center has developed PANACEA (PANcancer Analysis of Chemical Entity Activity), a collection of dose-response curves and perturbational profiles for 400 clinical oncology drugs in cell lines selected to optimally represent 19 cancer subtypes. This resource, developed to study tumor-specific drug mechanism of action, was instrumental in hosting a DREAM Challenge to assess computational models for de novo drug polypharmacology prediction. Dose-response and perturbational profiles for 32 kinase inhibitors were provided to 21 participating teams who were asked to predict high-affinity binding target among 255 possible protein kinases. Best performing methods leveraged both gene expression profile similarity analysis, and deep-learning methodologies trained on individual datasets. This study lays the foundation for future integrative analyses of pharmacogenomic data, reconciliation of polypharmacology effects in different tumor contexts, and insights into network-based assessment of context-specific drug mechanism of action.
- Open Access
- 6 December 2016
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 33 (5) , 701-709
Network-based analysis of omics data: the LEAN method
Most computational approaches for the analysis of omics data in the context of interaction networks have very long running times, provide single or partial, often heuristic, solutions and/or contain user-tuneable parameters. We introduce local enrichment analysis (LEAN) for the identification of dysregulated subnetworks from genome-wide omics datasets. By substituting the common subnetwork model with a simpler local subnetwork model, LEAN allows exact, parameter-free, efficient and exhaustive identification of local subnetworks that are statistically dysregulated, and directly implicates single genes for follow-up experiments. Evaluation on simulated and biological data suggests that LEAN generally detects dysregulated subnetworks better, and reflects biological similarity between experiments more clearly than standard approaches. A strong signal for the local subnetwork around Von Willebrand Factor (VWF), a gene which showed no change on the mRNA level, was identified by LEAN in transcriptome data in the context of the genetic disease Cerebral Cavernous Malformations (CCM). This signal was experimentally found to correspond to an unexpected strong cellular effect on the VWF protein. LEAN can be used to pinpoint statistically significant local subnetworks in any genome-scale dataset. The R-package LEANR implementing LEAN is supplied as supplementary material and available on CRAN (https://cran.r-project.org). Supplementary data are available at Bioinformatics online.
- 6 December 2016
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 33 (5) , 701-709
Open AccessNetwork-based analysis of omics data: the LEAN method
Most computational approaches for the analysis of omics data in the context of interaction networks have very long running times, provide single or partial, often heuristic, solutions and/or contain user-tuneable parameters. We introduce local enrichment analysis (LEAN) for the identification of dysregulated subnetworks from genome-wide omics datasets. By substituting the common subnetwork model with a simpler local subnetwork model, LEAN allows exact, parameter-free, efficient and exhaustive identification of local subnetworks that are statistically dysregulated, and directly implicates single genes for follow-up experiments. Evaluation on simulated and biological data suggests that LEAN generally detects dysregulated subnetworks better, and reflects biological similarity between experiments more clearly than standard approaches. A strong signal for the local subnetwork around Von Willebrand Factor (VWF), a gene which showed no change on the mRNA level, was identified by LEAN in transcriptome data in the context of the genetic disease Cerebral Cavernous Malformations (CCM). This signal was experimentally found to correspond to an unexpected strong cellular effect on the VWF protein. LEAN can be used to pinpoint statistically significant local subnetworks in any genome-scale dataset. The R-package LEANR implementing LEAN is supplied as supplementary material and available on CRAN (https://cran.r-project.org). Supplementary data are available at Bioinformatics online.